Merck & Co Inc
MRK · Healthcare · Pharmaceuticals
Updated 26 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #51 of 500 by Iconic Score · #5 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Merck & Co Inc (MRK) is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. With a market capitalization of $305.1 billion, Merck is recognized for its innovative research and development, particularly in oncology, infectious diseases, and vaccines, including its well-known HPV vaccine, Gardasil, and the blockbuster cancer treatment, Keytruda. The company maintains a strong market position, leveraging a robust pipeline of new therapies and a commitment to addressing unmet medical needs. Merck's focus on scientific advancement and strategic partnerships enhances its competitive edge in the pharmaceutical sector, making it a significant player in improving global health outcomes. Its ongoing efforts in sustainability and access to medicines further underscore its importance in the healthcare landscape.
IconicOracleAI™ Brief
Merck & Co Inc (MRK) currently holds an Iconic Score of 69, reflecting strong brand visibility with a score of 85/100 from logo analysis. Recent headlines highlight Merck's competitive positioning in the pharmaceutical sector, with positive sentiment noted in discussions about its stock performance relative to peers like Johnson & Johnson and Eli Lilly. The company's market cap of $365.9B and a price increase of 1.07% further indicate a solid presence in the market amid ongoing industry conversations.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.